The objective of this work was the phylogenetic characterization of local clinical isolates of uropathogenic E. coli with respect to drug resistance. A total of 59 uropathogenic E. coli responsible for community acquired urinary tract infections were included in this study. A triplex PCR was employed to segregate each isolate into four different phylogenetic groups (A, B1, B2 and D). Drug resistance was evaluated by disc diffusion method. The drugs used were ampicillin, aztreonam, cefixime, cefoperazone, ceftriaxone, cephradine among β-lactam group; amikacin, gentamicin, and streptomycin among aminoglycosides; nalidixic acid and ciprofloxacin from quinolones; trimethoprim-sulfomethoxazole, and tetracycline. Among 59 uropathogenic E. coli isolates majority belonged to phylogenetic group B2 (50%) where as 19% each belonged to groups A and B1, and 12% to group D. All the isolates were multiple drug resistant (MDR).
INTRODUCTION
Community acquired urinary tract infections (UTI) are highly prevalent in developing countries and are usually difficult to eradicate because the pathogenic bacteria have acquired resistance to most of the drugs. UTI has been shown to be an independent risk factor for both bladder cancer and renal cell carcinoma (18) . Women are more likely to experience UTI than men. UTIs affect a large proportion of the world population and are responsible for significant morbidity and high medical costs (1, 5) . Multiple drug resistance patterns of uropathogenic E. coli infections (10) . The frequent use of antibiotics is considered the most important factor which promotes multiple drug resistance (MDR) in UPEC in both veterinary and human medicine (14) . Due to indiscriminate use of drugs in developing countries, the pathogenic bacteria are much more dynamic, versatile and 'battle-hardened' as compared with developed countries. Therefore, it is predictable that they show variance from established traits. Thus the purpose of this study was to explore local UPEC with respect to phylogenicity and drug resistance. This is the first such report from Pakistan.
MATERIALS AND METHODS

Collection of samples
For this study clinically diagnosed patients for UTI were selected from different clinical laboratories of Faisalabad, Pakistan. The criteria included urge to urinate frequently, sharp pain or burning sensation in urethra when urine was released and pyuria. Midstream urine samples were collected in sterile bottles. These samples were stored and transferred to our laboratory at 4°C within one week. Only the samples with significant bacteriuria (more than 10 5 cfu per ml) were included.
Isolation and confirmation of UPEC
The samples were directly inoculated on MacConkey agar plates. After overnight incubation at 37°C, lactose-fermenting colonies were inoculated on triple sugar iron (TSI) slants for biochemical identification. Confirmation was done by PCR as described below. Fifty-nine UPEC isolates responsible for community acquired UTIs were included in this study.
DNA was extracted by the conventional phenol- 
Phylogenetic classification
The UPEC were assigned to one of the four phylogenetic groups (A, B1, B2 and D) by targeting two marker genes chuA Multiple drug resistance patterns of uropathogenic E. coli 
RESULTS
Phylogenetic classification
A total of 59 isolates were identified by conventional biochemical identification on TSI slants and confirmed by 
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Drug sensitivity by disc diffusion method
These isolates were highly resistant to cephradine and ampicillin. However, resistance to some other β-lactam drugs such as aztreonam, and cephalosporins, ceftriaxone, cefoperazone and cefixime was to a lesser degree. Among aminoglycosides, although resistance to streptomycin was very high, gentamicin and amikacin were relatively more effective.
Trimethoprim-sulfamethoxazole and tetracycline were largely ineffective. Nalidixic acid was relatively ineffective but as expected fluoroquinolone, ciprofloxacin showed better results.
A total of 43 patterns were observed among E. coli isolates and none of the isolates was resistant to less than 4 drugs, so all isolates were considered as multiple drug resistant (MDR) ( Table 1) . Table 1 . Prevalence of multiple drug resistance among various phylogenetic groups of uropathogenic E. coli isolates
Drug sensitivity of different phylogenetic groups
The results of drug resistance according to phylogenetic groups are shown in Table 1 . Dominating group among our local UPEC isolates was B2 (50%). The isolates belonging to this group were highly resistant to all drugs except gentamicin (47%), ceftriaxone (50%) and amikacin (53%). Group D (12%)
isolates were totally resistant to all drugs except cefoperazone , aztreonam, amikacin, gentamicin (86% each), and ceftriaxone (71%). Resistance of Group A (19%) isolates to the used drugs was generally high with exception of amikacin (45%), cefixime, aztreonam and gentamicin (55% each). Group B1 (19%) isolates were highly resistant to all drugs except nalidixic acid (36%), ciprofloxacin (36%) and ceftriaxone (36%). Phylogenetic group D isolates were found to be most drug resistant followed by phylogenetic group B2, A and B1 (Table 1) .
DISCUSSION
Phylogenetic analysis differentiates all uropathogenic isolates into four groups, A, B1, B2 and D. In our study, 50%
of isolates belonged to group B2, 19% each represented group A and B1 and 12% were members of group D. Our findings are in line with other studies where it was found that virulent isolates of E. coli mainly belong to phylogenetic group B2 and D, where as less virulent and commensal isolates of E. coli belong to phylogenetic groups B1 and A (11). However, we Multiple drug resistance patterns of uropathogenic E. coli found that unlike some previous reports (2, 15) , phylogenetic group D isolates were less frequent but more drug resistant as compared to phylogenetic groups B2, A and B1 (Table 1 ). It is difficult to explain but probably different environmental and social conditions play an important role.
All the 59 isolates studied showed resistance to at least 4 drugs by disc diffusion methods. So they can be labeled as MDR (3, 25) . The emergence of 43 drug resistance patterns showed high variability among local UPEC isolates.
All isolates were highly resistant to ampicillin, which is in agreement to the findings of Nagoba et al. (16 Our study showed that all group D isolates were resistant to quinolones. High level of resistance was also seen in B2 and A groups, where as B1 isolates were mostly susceptible. These findings are in partial disagreement with Takahashi et al. (23) who reported that phylogenetic group B2 was significantly less prevalent in fluoroquinolone resistant E. coli than in susceptible E. coli (49% versus 78%).
One interesting finding was that the group A isolates which are supposed to represent commensal E. coli exhibited high level of drug resistance which was though less than group D isolates but was at par with group B2 isolates (11).
Among aminoglycosides, 97% resistance was observed for streptomycin, 63% for gentamicin and 56% for amikacin.
As was the case for other drugs, group D was dominant in level of drug resistance. Similar studies indicating relative efficacy of gentamicin and amikacin have been reported from Pakistan (4). However it has also been reported that there is an increase in resistance against these drugs in urinary E. coli (9) . These researchers did not study phylogenicity.
It can be concluded that all local UPEC are multiple drug resistant (MDR) which make them a serious and challenging health problem. Prevalence of various phylogenetic groups was in agreement with reported data but strong variance was seen in level of drug resistance. Previous reports indicate that phylogenetic group B2 is more drug resistant where as we found that among local isolates, group D isolates are most problematic in this respect.
